What is Joubert Syndrome?
Joubert syndrome (JS) is a rare autosomal recessive neurodevelopmental ciliopathy characterized by a distinctive cerebellar and brainstem malformation that produces the pathognomonic "molar tooth sign" on brain MRI, along with hypotonia, ataxia, developmental delay, abnormal eye movements, and variable multiorgan involvement 1, 2.
Core Neurological Features
The neurological presentation is defined by:
- Cerebellar vermis hypoplasia with the diagnostic "molar tooth sign" (MTS) visible on axial brain MRI, consisting of thickened cerebellar peduncles and a deepened interpeduncular fossa 3, 4
- Hypotonia that evolves into ataxia (present in 80-100% of cases) 5
- Developmental delay and intellectual disability (100% of cases) 5
- Abnormal eye movements, particularly oculomotor apraxia (80-95% of cases) 6, 5
- Neonatal breathing abnormalities with irregular respiratory rhythm (25% of cases) 3, 5
Multisystem Involvement
Only 34% of individuals have "pure JS" limited to neurological features 7. The majority have additional organ system involvement:
- Retinal disease/dystrophy: 30-38% of patients, particularly with AHI1 and CEP290 mutations 7, 6
- Renal disease: 25% develop kidney involvement, including nephronophthisis and renal cysts 1, 7
- Hepatic fibrosis: 14% of cases, strongly associated with TMEM67 mutations 7
- Coloboma: 17% of patients, also linked to TMEM67 mutations 7
- Polydactyly: 15% of cases 7
- Encephalocele: 8% of patients 7
Additional ocular findings include strabismus (74%), nystagmus (72%), ptosis (43%), and optic nerve atrophy (22%) 6.
Genetic Basis
JS demonstrates extreme genetic heterogeneity with mutations in over 30 genes identified, all encoding proteins of the primary cilium or its apparatus 1, 7, 4. This classifies JS as a ciliopathy with clinical and genetic overlap with other ciliary disorders including Meckel syndrome, Bardet-Biedl syndrome, and nephronophthisis 3.
Key pathogenic genes include:
- CPLANE1, RPGRIP1L, MKS1, CC2D2A, CEP120, AHI1 5
- CEP290 (associated with retinal dystrophy) 7
- TMEM67 (associated with liver fibrosis and coloboma) 7
- B9D2 (recently identified) 7
Molecular diagnosis is achieved in approximately 62% of cases using targeted gene sequencing or whole-exome sequencing 7, 5.
Diagnostic Approach
For any child presenting with developmental delay, abnormal eye movements, and hypotonia, immediately obtain brain MRI to identify the "molar tooth sign" and "midline cleft syndrome" 5. This imaging finding is pathognomonic and establishes the diagnosis 8.
The diagnostic workup should include:
- Brain MRI without contrast as the initial and definitive imaging study 8
- Diffusion tensor imaging can demonstrate absence of decussation of the superior cerebellar peduncles, a characteristic finding 8
- Genetic testing via whole-exome sequencing to identify the specific causative mutation 5
- Ophthalmologic examination for retinal dystrophy and other ocular abnormalities 2
- Renal ultrasound and function tests 2
- Liver function assessment 2
Clinical Pitfalls
Do not rely on CT imaging, as it has limited soft-tissue characterization and may miss the subtle brainstem and cerebellar malformations 8. MRI is mandatory for diagnosis 8.
The incidence is estimated at 1 in 80,000-100,000 live births globally 4, making it a rare condition that requires high clinical suspicion. Early recognition is critical because progressive complications can develop in the kidneys, liver, and retina, requiring subspecialty monitoring throughout the lifespan 2.